TY - JOUR
T1 - HTLV-1 uveitis in Colombia, an underrecognized complication of a hitherto neglected condition
T2 - a case series
AU - Villamil-Gomez, Wilmer
AU - Torres, Jaime R.
AU - Rojas-Hernández, Juan
AU - Reston, Torés Jose
AU - Vergara-Corena, Jairo
AU - Salgado, Patricia
AU - Viloria-Ruiz, Jorge
AU - Castro, Alvaro
AU - Cabrera Lasso, Andrés Mauricio
AU - Gotuzzo, Eduardo
N1 - Publisher Copyright:
© The Author(s), 2023.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Three Colombian patients with chronic HTLV-1 infection and severe intermediate and/or posterior uveitis are described. In one case, retinal ablation was necessary due to extensive peripheral degeneration, while the other two were successfully managed with local anti-inflammatory therapy. Gradual resolution of ocular findings was observed in all three patients on follow-up. Uveitis is a rarely recognized late complication of this infection, which represents a diagnostic and therapeutic challenge for clinicians in endemic countries. The real extension of HTLV-1 prevalence in Colombia and the frequency of its ophthalmologic complications remain to be determined.
AB - Three Colombian patients with chronic HTLV-1 infection and severe intermediate and/or posterior uveitis are described. In one case, retinal ablation was necessary due to extensive peripheral degeneration, while the other two were successfully managed with local anti-inflammatory therapy. Gradual resolution of ocular findings was observed in all three patients on follow-up. Uveitis is a rarely recognized late complication of this infection, which represents a diagnostic and therapeutic challenge for clinicians in endemic countries. The real extension of HTLV-1 prevalence in Colombia and the frequency of its ophthalmologic complications remain to be determined.
KW - A report of three cases in Colombia
KW - HTLV-1
KW - posterior uveitis
UR - https://www.scopus.com/pages/publications/85153614558
U2 - 10.1177/20499361231165864
DO - 10.1177/20499361231165864
M3 - Artículo
AN - SCOPUS:85153614558
SN - 2049-9361
VL - 10
JO - Therapeutic Advances in Infectious Disease
JF - Therapeutic Advances in Infectious Disease
ER -